Kennedy Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-89,432
Closed -$3.77M 724
2023
Q2
$3.77M Sell
89,432
-227
-0.3% -$9.18K 0.09% 354
2023
Q1
$3.19M Sell
89,659
-90,760
-50% -$3.29M 0.09% 339
2022
Q4
$6.62M Sell
180,419
-7,163
-4% -$283K 0.19% 187
2022
Q3
$8.84M Buy
187,582
+7,453
+4% +$481K 0.26% 115
2022
Q2
$12.9M Buy
180,129
+7,830
+5% +$572K 0.36% 72
2022
Q1
$13.9M Buy
172,299
+5,455
+3% +$461K 0.33% 88
2021
Q4
$17.1M Sell
166,844
-3,914
-2% -$376K 0.36% 68
2021
Q3
$14.9M Sell
170,758
-6,769
-4% -$613K 0.33% 74
2021
Q2
$15.9M Buy
177,527
+57,294
+48% +$4.84M 0.34% 73
2021
Q1
$9.12M Sell
120,233
-6,916
-5% -$521K 0.18% 203
2020
Q4
$8.66M Buy
127,149
+10,663
+9% +$665K 0.2% 177
2020
Q3
$6.19M Buy
116,486
+38,377
+49% +$2.29M 0.18% 199
2020
Q2
$4.55M Buy
+78,109
New +$4.2M 0.13% 302
2017
Q2
Sell
-74,760
Closed -$3.43M 763
2017
Q1
$3.43M Buy
+74,760
New +$3.72M 0.06% 513

Other funds holding SYNH

Kennedy Capital Management's SYNH Position: Q3 2023 in Review

Kennedy Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 89,432 shares — an estimated $3.77M sold.

Kennedy Capital Management first reported a position in SYNH in Q1 2017 and held it in 14 quarters. The position peaked at $17.1M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Kennedy Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Kennedy Capital Management sold 89,432 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $3.77M.
  • Kennedy Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 14 quarters.
  • Kennedy Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $17.1M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Kennedy Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.